DOI:
10.1055/s-00034924
Nuklearmedizin - NuclearMedicine
LinksClose Window
References
Putzer D, Kroiss A, Waitz D. et al.
Somatostatin receptor PET in neuroendocrine tumours: 68Ga-DOTAO,Tyr3-octreotide versus 68Ga-DOTAO-lan-reotide.
Eur J Nucl Med Mol Imaging 2013;
40: 364-372.
We do not assume any responsibility for the contents of the web pages of other providers.